PKI: Lowering target price to $142.00

PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets.

Subscribe to Yahoo Finance Plus Essential for full access

Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Try it Free